Skip to search formSkip to main contentSkip to account menu

ABT 239

Known as: ABT-239, ABT239 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Imaging histamine H3 receptors with [18F]FMH3: Test–retest and occupancy studies in the non‐human primate
A positron emission tomography (PET) radioligand, [18F]FMH3, has been developed to interrogate histamine receptor subtype 3 (H3R… 
Highly Cited
2010
Highly Cited
2010
H4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats
2010
2010
Effects of the H3 receptor antagonist ABT239 on nicotine-induced sensitization and memory enhancement in rodents
Review
2010
Review
2010
JPET Miniseries : H 3 Receptors Histamine and H 3 Receptor in Alcohol-Related Behaviors
Data from rat models for alcohol preference and histidine decarboxylase knockout (HDC KO) mice suggest that brain histamine… 
2009
2009
Use of the H3 receptor antagonist radioligand [3H]‐A‐349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonists
Background and purpose:  The histamine H3 receptor antagonist radioligand [3H]‐A‐349821 was characterized as a radiotracer for… 
2009
2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.
A new histamine H3 receptor (H3R) antagonist chemotype 1 was designed by combining key pharmacophoric elements from two different… 
2008
2008
A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
Guanosine 5'-O-(3-[(35)S]thio)triphosphate ([(35)S]GTPgammaS) binding assays were established and utilized as a reliable and high… 
2005
2005
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug–drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)